Cancel anytime
Nu Skin Enterprises Inc (NUS)NUS
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/15/2024: NUS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -26.18% | Upturn Advisory Performance 3 | Avg. Invested days: 20 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/15/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -26.18% | Avg. Invested days: 20 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/15/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 377.31M USD |
Price to earnings Ratio - | 1Y Target Price 8.25 |
Dividends yield (FY) 3.16% | Basic EPS (TTM) -2.09 |
Volume (30-day avg) 817751 | Beta 1.13 |
52 Weeks Range 5.95 - 20.42 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 377.31M USD | Price to earnings Ratio - | 1Y Target Price 8.25 |
Dividends yield (FY) 3.16% | Basic EPS (TTM) -2.09 | Volume (30-day avg) 817751 | Beta 1.13 |
52 Weeks Range 5.95 - 20.42 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-07 | When AfterMarket |
Estimate 0.19 | Actual 0.17 |
Report Date 2024-11-07 | When AfterMarket | Estimate 0.19 | Actual 0.17 |
Profitability
Profit Margin -5.81% | Operating Margin (TTM) 4.24% |
Management Effectiveness
Return on Assets (TTM) 5.55% | Return on Equity (TTM) -13.5% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 641299641 | Price to Sales(TTM) 0.21 |
Enterprise Value to Revenue 0.36 | Enterprise Value to EBITDA 81.62 |
Shares Outstanding 49711000 | Shares Floating 48667586 |
Percent Insiders 2.29 | Percent Institutions 81.14 |
Trailing PE - | Forward PE - | Enterprise Value 641299641 | Price to Sales(TTM) 0.21 |
Enterprise Value to Revenue 0.36 | Enterprise Value to EBITDA 81.62 | Shares Outstanding 49711000 | Shares Floating 48667586 |
Percent Insiders 2.29 | Percent Institutions 81.14 |
Analyst Ratings
Rating 3 | Target Price 27.75 | Buy - |
Strong Buy - | Hold 3 | Sell - |
Strong Sell - |
Rating 3 | Target Price 27.75 | Buy - | Strong Buy - |
Hold 3 | Sell - | Strong Sell - |
AI Summarization
Nu Skin Enterprises Inc.: A Comprehensive Overview
Company Profile:
Detailed history and background:
Nu Skin Enterprises Inc. is a global direct selling company founded in 1984 by Blake Roney. The company started by selling personal care products and has since expanded to include nutrition, anti-aging, and technology products.
Core business areas:
Nu Skin operates in the following core business areas:
- Personal care: This segment includes skincare, hair care, and other personal hygiene products.
- Nutrition: This segment offers a range of nutritional supplements, including vitamins, minerals, and protein powders.
- Anti-aging: This segment focuses on products that claim to slow down the aging process.
- Technology: This segment includes beauty devices and other technology-driven products.
Leadership and corporate structure:
Nu Skin is led by a team of experienced executives, including:
- Ritch Wood: Executive Chairman and Chief Innovation Officer
- Ryan Napierski: Chief Executive Officer
- Joseph Y. Chang: Chief Financial Officer
The company has a decentralized corporate structure, with regional offices located around the world.
Top Products and Market Share:
Top products and offerings:
Some of Nu Skin's top products include:
- ageLOC LumiSpa: A cleansing and anti-aging device.
- Pharmanex BioPhotonic Scanner: A scanner that claims to measure skin health.
- Nu Skin 180° Anti-Aging System: A skincare system that claims to reduce wrinkles and improve skin tone.
Market share:
Nu Skin holds a significant market share in the direct selling industry, particularly in the Asia-Pacific region. The company's market share varies depending on the product category and region.
Product performance and market reception:
Nu Skin's products have received mixed reviews from consumers and experts. Some products have been praised for their effectiveness, while others have been criticized for their high price point and lack of evidence-based claims.
Total Addressable Market:
The global direct selling market is estimated to be worth over $180 billion. Nu Skin operates in a large and growing market, with significant opportunities for future growth.
Financial Performance:
Recent financial statements:
Nu Skin's recent financial statements show that the company is financially healthy. The company has a strong track record of revenue growth and profitability.
Year-over-year comparison:
Nu Skin's financial performance has been relatively stable over the past few years. The company has continued to grow revenue and earnings, despite facing some challenges in certain markets.
Cash flow and balance sheet health:
Nu Skin has a strong cash flow position and a healthy balance sheet. The company has a low level of debt and ample liquidity.
Dividends and Shareholder Returns:
Dividend history:
Nu Skin has a history of paying dividends to shareholders. The company's recent dividend yield is around 2%.
Shareholder returns:
Nu Skin has generated strong shareholder returns over the past several years. The company's stock price has outperformed the broader market.
Growth Trajectory:
Historical growth:
Nu Skin has experienced strong historical growth, particularly in the Asia-Pacific region. The company has grown its revenue and earnings at a double-digit pace in recent years.
Future projections:
Nu Skin is expected to continue to grow in the future, driven by the expansion of its product portfolio and its focus on international markets.
Recent product launches and strategic initiatives:
Nu Skin has recently launched several new products, including a new line of anti-aging skincare products and a new line of nutritional supplements. The company is also investing heavily in its digital marketing efforts.
Market Dynamics:
Industry trends:
The direct selling industry is facing several challenges, including increased competition from online retailers and changing consumer preferences. However, the industry is also benefiting from the growing popularity of personalized products and experiences.
Nu Skin's position:
Nu Skin is well-positioned to succeed in the direct selling industry. The company has a strong brand, a loyal customer base, and a diversified product portfolio.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Nu Skin Enterprises Inc
Exchange | NYSE | Headquaters | Provo, UT, United States |
IPO Launch date | 1996-11-21 | President, CEO & Director | Mr. Ryan S. Napierski |
Sector | Consumer Defensive | Website | https://www.nuskin.com |
Industry | Household & Personal Products | Full time employees | 3700 |
Headquaters | Provo, UT, United States | ||
President, CEO & Director | Mr. Ryan S. Napierski | ||
Website | https://www.nuskin.com | ||
Website | https://www.nuskin.com | ||
Full time employees | 3700 |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.